Trademark: 79316047
Word
RENLITE
Status
Registered
Status Code
700
Status Date
Tuesday, May 3, 2022
Serial Number
79316047
Registration Number
6714947
Registration Date
Tuesday, May 3, 2022
Mark Type
4000
Filing Date
Wednesday, February 24, 2021
Published for Opposition
Tuesday, February 15, 2022

Trademark Owner History

Classifications
5 Vaccines; pharmaceutical preparations for the treatment of immune system related diseases and disorders; medicines for the treatment of cancer; diagnostic preparations for medical purposes; biochemical medicines for the treatment of tumors, infectious diseases, inflammation and autoimmune diseases; medicines for human purposes for the treatment of tumors, infectious diseases, inflammation and autoimmune diseases; drugs for medical purposes for the treatment of tumors, infectious diseases, inflammation and autoimmune diseases; biological preparations for medical purposes for the treatment of tumors, infectious diseases, inflammation and autoimmune diseases; active pharmaceutical ingredients being chemical and biological preparations for pharmaceutical purposes, namely, antibodies for the treatment of human and animal diseases; diagnostic preparations for medical and veterinary purposes; dietetic preparations adapted for medical use; medicines for veterinary purposes for the treatment of tumors, infectious diseases, inflammation and autoimmune diseases
31 Live trees; live plants; live animals; poultry, live; pigs, live; hamsters, live; live laboratory animals; plant seeds; fodder; litter for animals
42 Evaluation of pharmaceutical products; technological research, namely, pharmaceutical research; conducting early evaluation in the field of new pharmaceuticals; development of products for others; consulting services in the field of technology development in the fields of pharmaceutical research and development; research and development of new products; pharmaceutical research services; quality control inspection in the field of pharmaceutical research and development; biochemical research and analysis; research and development services in the field of antibodies; medical and scientific research, namely, conducting clinical trials for others; biological research; development of pharmaceutical preparations and medicines; product testing; pharmaceutical products development services
REN LITE; REN LIGHT

Trademark Events
Sep 4, 2022
Generic Madrid Transaction Sent To Ib
Sep 4, 2022
Generic Madrid Transaction Created
Aug 3, 2022
Final Disposition Notice Created, To Be Sent To Ib
May 3, 2022
Registered-Principal Register
Feb 15, 2022
Official Gazette Publication Confirmation E-Mailed
Feb 15, 2022
Published For Opposition
Feb 14, 2022
Notification Processed By Ib
Jan 26, 2022
Notification Of Possible Opposition Sent To Ib
Jan 26, 2022
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Jan 26, 2022
Notification Of Notice Of Publication E-Mailed
Jan 8, 2022
Approved For Pub - Principal Register
Jan 7, 2022
Teas/Email Correspondence Entered
Jan 7, 2022
Correspondence Received In Law Office
Jan 7, 2022
Teas Response To Office Action Received
Nov 5, 2021
Refusal Processed By Ib
Oct 8, 2021
Non-Final Action Mailed - Refusal Sent To Ib
Oct 8, 2021
Refusal Processed By Mpu
Sep 24, 2021
Non-Final Action (Ib Refusal) Prepared For Review
Sep 23, 2021
Non-Final Action Written
Sep 19, 2021
Assigned To Examiner
Jul 31, 2021
Application Filing Receipt Mailed
Jul 27, 2021
New Application Office Supplied Data Entered In Tram
Jul 22, 2021
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24